1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Product Code | NK-92MI (NFkB) Luciferase Cell Line |
Cat.No | ABC-RC506H |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Transfected Stable Cell Lines |
Size/Quantity | 1 vial |
Cell Type | NK Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Peripheral Blood |
Disease | Lymphoma |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Reporter Stable Cell Line |
Host Cell | NK-92MI Cell Line |
The NK-92MI (NFkB) Luciferase cell line is transformed from NK-92MI cell, expressing the firefly luciferase gene. The cell constitutively express Luciferase.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
For research use only
The NK-92MI (NFkB) Luciferase Reporter Cell Line is a genetically engineered version of the NK-92MI natural killer cell line, modified to express a luciferase reporter gene under the control of an NF-kB responsive promoter. This allows researchers to study NF-kB activity by detecting luminescent signals.
This cell line is used to investigate the NF-kB signaling pathway, which plays a critical role in immune responses, inflammation, and cancer. It enables researchers to monitor NF-kB activation in real-time, assess the effects of various compounds on NF-kB signaling, and conduct high-throughput screening for potential therapeutic agents.
The luciferase reporter system enhances the study of NF-kB signaling by providing a quantifiable and sensitive method to measure NF-kB activity. The luminescent signal produced is directly proportional to the activity of NF-kB, allowing researchers to precisely monitor and quantify changes in response to various stimuli or treatments, facilitating a deeper understanding of NF-kB-related cellular processes.